WithdrawnNot Applicable

Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Stopped: 0 participants

0Started 2020-06-16

Plain-language summary

This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓--All patients undergoing surgery to resect spinal tumors

Exclusion criteria

✕--None

What they're measuring

Viability assays

Timeframe: 3 years

Functional assays

Timeframe: 3 years

Trial details

NCT IDNCT04533919

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-30

View on ClinicalTrials.gov More Spinal Cord Neoplasm trials